Generic placeholder image

Recent Patents on Endocrine, Metabolic & Immune Drug Discovery

Editor-in-Chief

ISSN (Print): 1872-2148
ISSN (Online): 2212-3334

GLP - 1 Analogs: Newer Molecules, Newer Uses

Author(s): Sanjay Kalra, Bharti Kalra and Amit Kumar

Volume 3, Issue 2, 2009

Page: [129 - 134] Pages: 6

DOI: 10.2174/187221409788452309

Price: $65

Abstract

Much interest has focused on the newer incretin-based therapeutic modalities for diabetes, especially GLP-1 analogues. While the comparatively older GLP-1 analogs, exenatide and liraglutide, have been discussed extensively in literature, much less is known about the newer GLP-1 analogues in the pipeline. This review focuses on the newer molecules being studied, the newer routes of administration being tried, some recent patents and potential uses for these multifaceted compounds.

Keywords: GLP-1 analogs, long acting exenatide, albiglutide, taspoglutide, GLP-2 analogs, GLP-1 secretagogues


Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy